Instead, IL-12 sensitized bone marrow-derived tumor stromal cells, including CD11b+F4/80hi macrophages, CD11b+MHCIIhiCD11chi DCs, and CD11b+Gr-1hi MDSCs, causing them to enhance the effects of adoptively transferred CD8+ T cells. The gene discussed is ITGAM; the disease is neoplasm.